Literature DB >> 14694101

Conserved C-terminal threonine of hepatitis C virus NS3 regulates autoproteolysis and prevents product inhibition.

Wenyan Wang1, Frederick C Lahser, MinKyung Yi, Jacquelyn Wright-Minogue, Ellen Xia, Patricia C Weber, Stanley M Lemon, Bruce A Malcolm.   

Abstract

Inspection of over 250 hepatitis C virus (HCV) genome sequences shows that a threonine is strictly conserved at the P1 position in the NS3-NS4A (NS3-4A) autoproteolysis junction, while a cysteine is maintained as the P1 residue in all of the putative trans cleavage sites (NS4A-4B, NS4B-5A, and NS5A-5B). To understand why T631 is conserved at the NS3-4A junction of HCV, a series of in vitro transcription-translation studies were carried out using wild-type and mutant (T631C) NS3-4A constructs bearing native, truncated, and mutant NS4A segments. The autocleavage of the wild-type junction was found to be dependent on the presence of the central cofactor domain of NS4A (residues 21 to 34). In contrast, all NS3-4A T631C mutant proteins underwent self-cleavage even in the absence of the cofactor. Subgenomic replicons derived from the Con1 strain of HCV and bearing the T631C mutation showed reduced levels of colony formation in transfection studies. Similarly, replicons derived from a second genotype 1b virus, HCV-N, demonstrated a comparable reduction in replication efficiency in transient-transfection assays. These data suggest that the threonine is conserved at position 631 because it serves two functions: (i) to slow processing at the NS3-4A cleavage site, ensuring proper intercalation of the NS4A cofactor with NS3 prior to polyprotein scission, and (ii) to prevent subsequent product inhibition by the NS3 C terminus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14694101      PMCID: PMC368748          DOI: 10.1128/jvi.78.2.700-709.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Enhancement of hepatitis C virus NS3 proteinase activity by association with NS4A-specific synthetic peptides: identification of sequence and critical residues of NS4A for the cofactor activity.

Authors:  N J Butkiewicz; M Wendel; R Zhang; R Jubin; J Pichardo; E B Smith; A M Hart; R Ingram; J Durkin; P W Mui; M G Murray; L Ramanathan; B Dasmahapatra
Journal:  Virology       Date:  1996-11-15       Impact factor: 3.616

2.  Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide.

Authors:  J L Kim; K A Morgenstern; C Lin; T Fox; M D Dwyer; J A Landro; S P Chambers; W Markland; C A Lepre; E T O'Malley; S L Harbeson; C M Rice; M A Murcko; P R Caron; J A Thomson
Journal:  Cell       Date:  1996-10-18       Impact factor: 41.582

3.  Substrate specificity of the hepatitis C virus serine protease NS3.

Authors:  A Urbani; E Bianchi; F Narjes; A Tramontano; R De Francesco; C Steinkühler; A Pessi
Journal:  J Biol Chem       Date:  1997-04-04       Impact factor: 5.157

4.  Complex formation between the NS3 serine-type proteinase of the hepatitis C virus and NS4A and its importance for polyprotein maturation.

Authors:  R Bartenschlager; V Lohmann; T Wilkinson; J O Koch
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

5.  The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site.

Authors:  R A Love; H E Parge; J A Wickersham; Z Hostomsky; N Habuka; E W Moomaw; T Adachi; Z Hostomska
Journal:  Cell       Date:  1996-10-18       Impact factor: 41.582

6.  A central hydrophobic domain of the hepatitis C virus NS4A protein is necessary and sufficient for the activation of the NS3 protease.

Authors:  L Tomei; C Failla; R L Vitale; E Bianchi; R De Francesco
Journal:  J Gen Virol       Date:  1996-05       Impact factor: 3.891

7.  Activity of purified hepatitis C virus protease NS3 on peptide substrates.

Authors:  C Steinkühler; A Urbani; L Tomei; G Biasiol; M Sardana; E Bianchi; A Pessi; R De Francesco
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

8.  Identification of the sequence on NS4A required for enhanced cleavage of the NS5A/5B site by hepatitis C virus NS3 protease.

Authors:  Y Shimizu; K Yamaji; Y Masuho; T Yokota; H Inoue; K Sudo; S Satoh; K Shimotohno
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

9.  Epitope mapping of the NS4 and NS5 gene products of hepatitis C virus and the use of a chimeric NS4-NS5 synthetic peptide for serodiagnosis.

Authors:  C Rosa; S Osborne; F Garetto; S Griva; A Rivella; G Calabresi; R Guaschino; F Bonelli
Journal:  J Virol Methods       Date:  1995-10       Impact factor: 2.014

10.  In vitro studies on the activation of the hepatitis C virus NS3 proteinase by the NS4A cofactor.

Authors:  J O Koch; V Lohmann; U Herian; R Bartenschlager
Journal:  Virology       Date:  1996-07-01       Impact factor: 3.616

View more
  11 in total

1.  Construction of eukaryotic expression plasmid containing HCV NS3 segment and protein expression in human HL-7702 hepatocytes.

Authors:  Jun-Wu Li; Ke Li; Jing Jiang; Xiao-Liang Xu; Ze-Qi Huang
Journal:  World J Gastroenterol       Date:  2006-02-21       Impact factor: 5.742

2.  A drug-controllable tag for visualizing newly synthesized proteins in cells and whole animals.

Authors:  Michael Z Lin; Jeffrey S Glenn; Roger Y Tsien
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-29       Impact factor: 11.205

3.  Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon.

Authors:  Adrien Breiman; Nathalie Grandvaux; Rongtuan Lin; Catherine Ottone; Shizuo Akira; Mitsutoshi Yoneyama; Takashi Fujita; John Hiscott; Eliane F Meurs
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

4.  Host proteins associated with Hepatitis C virus encoded NS4A.

Authors:  Prerna Dabral; Lohit Khera; Rajeev Kaul
Journal:  Virusdisease       Date:  2014-11-12

Review 5.  Hepatitis C: recent successes and continuing challenges in the development of improved treatment modalities.

Authors:  Tetsuro Shimakami; Robert E Lanford; Stanley M Lemon
Journal:  Curr Opin Pharmacol       Date:  2009-09-15       Impact factor: 5.547

6.  Hepatitis C viral NS3-4A protease activity is enhanced by the NS3 helicase.

Authors:  Rudolf K F Beran; Anna Marie Pyle
Journal:  J Biol Chem       Date:  2008-08-22       Impact factor: 5.157

7.  Increasing rate of cleavage at boundary between non-structural proteins 4B and 5A inhibits replication of hepatitis C virus.

Authors:  Morgan R Herod; Daniel M Jones; John McLauchlan; Christopher J McCormick
Journal:  J Biol Chem       Date:  2011-11-14       Impact factor: 5.157

8.  Genetic complementation of hepatitis C virus nonstructural protein functions associated with replication exhibits requirements that differ from those for virion assembly.

Authors:  Morgan R Herod; Vera Schregel; Chris Hinds; Mengya Liu; John McLauchlan; Christopher J McCormick
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

9.  Discovery of an allosteric mechanism for the regulation of HCV NS3 protein function.

Authors:  Susanne M Saalau-Bethell; Andrew J Woodhead; Gianni Chessari; Maria G Carr; Joseph Coyle; Brent Graham; Steven D Hiscock; Christopher W Murray; Puja Pathuri; Sharna J Rich; Caroline J Richardson; Pamela A Williams; Harren Jhoti
Journal:  Nat Chem Biol       Date:  2012-09-30       Impact factor: 15.040

10.  Sequential Phosphorylation of the Hepatitis C Virus NS5A Protein Depends on NS3-Mediated Autocleavage between NS3 and NS4A.

Authors:  Cho-Han Chiang; Yen-Ling Lai; Yu-Ning Huang; Chun-Chiao Yu; Christine C Lu; Guann-Yi Yu; Ming-Jiun Yu
Journal:  J Virol       Date:  2020-09-15       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.